Hunter Perkins Capital Management, LLC Pfizer Inc Transaction History

Hunter Perkins Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$36.12 - $41.79 $10,836 - $12,537	-300 Reduced 4.09%	7,036 $258,000
Q1 2023 Apr 14, 2023	SELL	$39.39 - $51.28 $12,998 - $16,922	-330 Reduced 4.3%	7,336 $299,000
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $34,495 - $42,744	754 Added 10.91%	7,666 $397,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $285,603 - $423,360	6,912 New	6,912 $408,000
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $981,257 - $1.11 Million	-29,300 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $980,671 - $1.25 Million	29,300 New	29,300 $1.08 Million

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.